Agarwal Arjun sold ORKA
May 18, 2026 · Form 4 insider transaction
Agarwal Arjun sold 700 shares of Oruka Therapeutics, Inc. at $61.16 per share, a transaction worth $42.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
700
Price
$61.16
Total value
$42.8K
InsiderAgarwal Arjun
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 18, 2026
Filing dateMay 18, 2026
Shares owned after16,406
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.82 to $61.76, inclusive.